Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...

Bausch + Lomb announced today that, after engagement with potential buyers, it has no immediate plan to sell. At the end of ...

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences business.

Boston Scientific (NYSE: BSX) shares ticked up slightly before hours today on fourth-quarter results that beat the consensus ...

The Personal Exoskeleton in use. [Image courtesy of Wandercraft] Wandercraft announced that it kicked off a landmark clinical ...

Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology ...

RapidAI announced that it received FDA 510(k) clearance for its Lumina 3D automated 3D imaging reconstruction solution.

The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

Movano Health (Nasdaq:MOVE) announced today that it commenced a blood pressure clinical trial with its new cuffless wrist ...

In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

Pulse Biosciences (Nasaq:PLSE) announced today that it appointed Jon Skinner as CFO, effective Feb. 3, 2025.